Spatial characterisation of b-catenin-mutated hepatocellular adenoma subtypes by proteomic profiling of the tumour rim

被引:0
作者
Tommaso, Sylvaine Di [1 ,2 ]
Dourthe, Cyril [1 ,2 ]
Dupuy, Jean -William [3 ]
Dugot-Senant, Nathalie [4 ]
Cappellen, David [1 ,5 ]
Cazier, Helene [6 ]
Paradis, Valerie [6 ]
Blanc, Jean-Frederic [1 ,7 ]
Bail, Brigitte Le [1 ,8 ]
Balabaud, Charles [1 ]
Bioulac-Sage, Paulette [1 ]
Saltel, Frederic [1 ,2 ,9 ]
Raymond, Anne-Aurelie [1 ,2 ,9 ]
机构
[1] Univ Bordeaux, BoRdeaux Inst onCol BRIC, Inserm, UMR1312, Bordeaux, France
[2] Oncoprot Platform, TBM Core US 005, Bordeaux, France
[3] Univ Bordeaux, Prote Platform, Bordeaux, France
[4] TBM Core US 005, Histol Platform, Bordeaux, France
[5] Bordeaux Univ Hosp Ctr, Tumor Bank & Tumor Biol Lab, Pessac, France
[6] Henri Mondor Hosp, AP HP, Pathol Dept, Creteil, France
[7] Bordeaux Univ Hosp, Dept Hepatol & Oncol, INSERM, CIC 1401, Bordeaux, France
[8] Bordeaux Univ Hosp, Pathol Dept, Bordeaux, France
[9] BoRdeaux Inst onCol BRIC, INSERM, UMR1312, 146 Rue Leo Saignat, F-33076 Bordeaux, France
关键词
Hepatocellular adenoma; Tumour heterogeneity; Tumour rim; 8-Catenin mutation; Glutamine synthetase; Proteomic profiling; METHYLACYL-COA RACEMASE; MOLECULAR CLASSIFICATION; MALIGNANT-TRANSFORMATION; GLUTAMINE-SYNTHETASE; RISK-FACTORS; EXPRESSION;
D O I
10.1016/j.jhepr.2023.100913
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Hepatocellular adenomas (HCAs) are rare, benign, liver tumours classified at the clinicopathological, genetic, and proteomic levels. The 8-catenin-activated (b-HCA) subtypes harbour several mutation types in the 8-catenin gene (CTNNB1) associated with different risks of malignant transformation or bleeding. Glutamine synthetase is a surrogate marker of 8-catenin pathway activation associated with the risk of malignant transformation. Recently, we revealed an overexpression of glutamine synthetase in the rims of exon 3 S45 -mutated b-HCA and exon 7/8 -mutated b-HCA compared with the rest of the tumour. A difference in vascularisation was found in this rim shown by diffuse CD34 staining only at the tumour centre. Here, we aimed to characterise this tumour heterogeneity to better understand its physiopathological involvement. Methods: Using mass spectrometry imaging, genetic, and proteomic analyses combined with laser capture microdissection, we compared the tumour centre with the tumour rim and with adjacent non-tumoural tissue. Results: The tumour rim harboured the same mutation as the tumour centre, meaning both parts belong to the same tumour. Mass spectrometry imaging showed different spectral profiles between the rim and the tumour centre. Proteomic profiling revealed the significant differential expression of 40 proteins at the rim compared with the tumour centre. The majority of these proteins were associated with metabolism, with an expression profile comparable with a normal perivenous hepatocyte expression profile. Conclusions: The difference in phenotype between the tumour centres and tumour rims of exon 3 S45 -mutated b-HCA and exon 7/8 -mutated b-HCA does not depend on CTNNB1 mutational status. In a context of sinusoidal arterial pathology, tumour heterogeneity at the rim harbours perivenous characteristics and could be caused by a functional peripheral venous drainage. Impact and implications: Tumour heterogeneity was revealed in 8-catenin-mutated hepatocellular adenomas (b-HCAs) via the differential expression of glutamine synthase at tumour rims. The combination of several spatial approaches (mass spectrometry imaging, genetic, and proteomic analyses) after laser capture microdissection allowed identification of a potential role for peripheral venous drainage underlying this difference. Through this study, we were able to illustrate that beyond a mutational context, many factors can downstream regulate gene expression and contribute to different clinicopathological phenotypes. We believe that the combinations of spatial analyses that we used could be inspiring for all researchers wanting to access heterogeneity information of liver tumours. (c) 2023 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL). This is an open access article under the CC BY -NC -ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:11
相关论文
共 32 条
[1]   Recurrent chromosomal rearrangements of ROS1, FRK and IL6 activating JAK/STAT pathway in inflammatory hepatocellular adenomas [J].
Bayard, Quentin ;
Caruso, Stefano ;
Couchy, Gabrielle ;
Rebouissou, Sandra ;
Sage, Paulette Bioulac ;
Balabaud, Charles ;
Paradis, Valerie ;
Sturm, Nathalie ;
de Muret, Anne ;
Guettier, Catherine ;
Bonsang, Benjamin ;
Copie, Christiane ;
Letouze, Eric ;
Calderaro, Julien ;
Imbeaud, Sandrine ;
Nault, Jean-Charles ;
Zucman-Rossi, Jessica .
GUT, 2020, 69 (09) :1667-1676
[2]  
Bioulac-Sage P, 2019, WHO classification of tumors, V5th
[3]   Hepatocellular adenoma subtype classification using molecular markers and lmmunohistochemistry [J].
Bioulac-Sage, Paulette ;
Rebouissou, Sandra ;
Thomas, Cristel ;
Blanc, Jean-Frederic ;
Saric, Jean ;
Cunha, Antonio Sa ;
Ruiller, Anne ;
Cubel, Gaeelle ;
Couchy, Gabrielle ;
Imbeaud, Sandrine ;
Balabaud, Charles ;
Zucman-Rossi, Jessica .
HEPATOLOGY, 2007, 46 (03) :740-748
[4]   Hepatocellular adenoma: what we know, what we do not know, and why it matters [J].
Bioulac-Sage, Paulette ;
Gouw, Annette S. H. ;
Balabaud, Charles ;
Sempoux, Christine .
HISTOPATHOLOGY, 2022, 80 (06) :878-897
[5]   Hepatocellular adenoma: Classification, variants and clinical relevance [J].
Bioulac-Sage, Paulette ;
Sempoux, Christine ;
Balabaud, Charles .
SEMINARS IN DIAGNOSTIC PATHOLOGY, 2017, 34 (02) :112-125
[6]   Proline: an efficient and user-friendly software suite for large-scale proteomics [J].
Bouyssie, David ;
Hesse, Anne-Marie ;
Mouton-Barbosa, Emmanuelle ;
Rompais, Magali ;
Macron, Charlotte ;
Carapito, Christine ;
de Peredo, Anne Gonzalez ;
Coute, Yohann ;
Dupierris, Veronique ;
Burel, Alexandre ;
Menetrey, Jean-Philippe ;
Kalaitzakis, Andrea ;
Poisat, Julie ;
Romdhani, Aymen ;
Burlet-Schiltz, Odile ;
Cianferani, Sarah ;
Garin, Jerome ;
Bruley, Christophe .
BIOINFORMATICS, 2020, 36 (10) :3148-3155
[7]   Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells [J].
Castelli, Germana ;
Pelosi, Elvira ;
Testa, Ugo .
CANCERS, 2017, 9 (09)
[8]   Proteomic Profiling of Hepatocellular Adenomas Paves the Way to Diagnostic and Prognostic Approaches [J].
Dourthe, Cyril ;
Julien, Celine ;
Di Tommaso, Sylvaine ;
Dupuy, Jean-William ;
Dugot-Senant, Nathalie ;
Brochard, Alexandre ;
Le Bail, Brigitte ;
Blanc, Jean-Frederic ;
Chiche, Laurence ;
Balabaud, Charles ;
Bioulac-Sage, Paulette ;
Saltel, Frederic ;
Raymond, Anne-Aurelie .
HEPATOLOGY, 2021, 74 (03) :1595-1610
[9]   Screening the molecular targets of ovarian cancer based on bioinformatics analysis [J].
Du, Lei ;
Qian, Xiaolei ;
Dai, Chenyang ;
Wang, Lihua ;
Huang, Ding ;
Wang, Shuying ;
Shen, Xiaowei .
TUMORI JOURNAL, 2015, 101 (04) :384-389
[10]   LIVER-CELL ADENOMAS ASSOCIATED WITH USE OF ORAL-CONTRACEPTIVES [J].
EDMONDSON, HA ;
HENDERSON, B ;
BENTON, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1976, 294 (09) :470-472